Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Community Based Intervention01:30

Community Based Intervention

Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Centered Prescription Opioid Tapering Methods : A Randomized Clinical Trial.

Annals of internal medicine·2026
Same author

Are self-management skills associated with depressive symptoms, quality of life, and healthcare utilisation? A cross-sectional survey among patients with advanced cancer in the Netherlands.

BMJ open·2026
Same author

Establishing Clinically Operational Domains of Multidimensional Frailty: A Consensus Approach to Improve Multidimensional Frailty Diagnosis at Point of Care.

The Gerontologist·2025
Same author

Midwives as trainers for a neonatal clinical decision support system at four rural health facilities in eastern Uganda: a mixed-methods observational study.

BMJ open·2024
Same author

Lifestyle Interventions for Obesity.

JAMA·2024
Same author

Remote Evidence-Based Programs for Health Promotion to Support Older Adults During the COVID-19 Pandemic and Beyond: Mixed Methods Outcome Evaluation.

JMIR aging·2024

Related Experiment Videos

Community-based peer-led diabetes self-management: a randomized trial.

Kate Lorig1, Philip L Ritter1, Frank J Villa1

  • 1Stanford University School of Medicine, USA.

The Diabetes Educator
|May 2, 2009
PubMed
Summary

A community-based diabetes self-management program improved participants' well-being and self-care skills, though not A1C levels, at 6 and 12 months. This peer-led intervention shows promise for diabetes education.

Related Experiment Videos

Area of Science:

  • Public Health
  • Behavioral Medicine
  • Chronic Disease Management

Background:

  • Type 2 diabetes management requires effective self-management strategies.
  • Community-based programs can enhance patient engagement and education.
  • Peer-led interventions offer a scalable approach to diabetes self-management.

Purpose of the Study:

  • To evaluate the effectiveness of a community-based diabetes self-management program (DSMP).
  • To compare DSMP participants with a usual-care control group at 6 months.
  • To assess long-term effects of the DSMP at 12 months.

Main Methods:

  • 345 adults with type 2 diabetes were randomized to DSMP or usual care.
  • The DSMP involved a 6-week community-based, peer-led intervention.
  • Outcomes measured included A1C, BMI, and self-reported data at baseline, 6, and 12 months.

Main Results:

  • No significant A1C improvement was observed at 6 months compared to controls.
  • DSMP participants showed significant improvements in depression, hypoglycemia symptoms, physician communication, healthy eating, and label reading at 6 months.
  • Improvements in depression, physician communication, healthy eating, patient activation, and self-efficacy were sustained at 12 months.

Conclusions:

  • Community-based, peer-led DSMPs can benefit individuals with type 2 diabetes, even without elevated A1C.
  • The program positively impacts psychosocial well-being and self-care behaviors.
  • The DSMP is a viable, low-cost option for diabetes education and support.